Jacqueline James
Overview
Explore the profile of Jacqueline James including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
531
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hamilton A, Bannon F, Dunne P, James J, McQuaid S, Gray R, et al.
Gastro Hep Adv
. 2024 Aug;
2(3):347-359.
PMID: 39132649
Background And Aims: The observed increase in the incidence of early-onset colorectal cancer (EOCRC) is being driven by sporadic cases, but the molecular characteristics of these tumors are not fully...
2.
Shephard A, Bashir R, Mahmood H, Jahanifar M, Minhas F, Raza S, et al.
NPJ Precis Oncol
. 2024 Jun;
8(1):137.
PMID: 38942998
Oral epithelial dysplasia (OED) is a premalignant histopathological diagnosis given to lesions of the oral cavity. Its grading suffers from significant inter-/intra-observer variability, and does not reliably predict malignancy progression,...
3.
Mahmood H, Shephard A, Hankinson P, Bradburn M, Araujo A, Santos-Silva A, et al.
Br J Cancer
. 2023 Sep;
129(10):1599-1607.
PMID: 37758836
Background: Oral epithelial dysplasia (OED) is the precursor to oral squamous cell carcinoma which is amongst the top ten cancers worldwide. Prognostic significance of conventional histological features in OED is...
4.
Humphries M, Bingham V, Abdullah Sidi F, Craig S, Lara B, El-Daly H, et al.
J Clin Pathol
. 2023 Jan;
76(6):418-423.
PMID: 36717223
Interrogation of immune response in autopsy material from patients with SARS-CoV-2 is potentially significant. We aim to describe a validated protocol for the exploration of the molecular physiopathology of SARS-CoV-2...
5.
Makhlouf Y, Salto-Tellez M, James J, OReilly P, Maxwell P
Diagnostics (Basel)
. 2022 May;
12(5).
PMID: 35626427
Integrating artificial intelligence (AI) tools in the tissue diagnostic workflow will benefit the pathologist and, ultimately, the patient. The generation of such AI tools has two parallel and yet interconnected...
6.
Alsanie I, Rajab S, Cottom H, Adegun O, Agarwal R, Jay A, et al.
Head Neck Pathol
. 2022 May;
16(4):1043-1054.
PMID: 35622296
Background: Salivary gland tumours (SGT) are a relatively rare group of neoplasms with a wide range of histopathological appearance and clinical features. To date, most of the epidemiological studies on...
7.
Greene C, ODoherty E, Sidi F, Bingham V, Fisher N, Humphries M, et al.
Biopreserv Biobank
. 2021 Mar;
19(4):324-331.
PMID: 33780631
Best practices dictate that biobanks ensure accurate determination of tumor content before supplying formalin-fixed, paraffin-embedded (FFPE) tissue samples to researchers for nucleic acid extraction and downstream molecular testing. It is...
8.
Sidi F, Bingham V, Craig S, McQuaid S, James J, Humphries M, et al.
Cancers (Basel)
. 2020 Dec;
13(1).
PMID: 33374775
Multiplex immunofluorescence (mIF) and digital image analysis (DIA) have transformed the ability to analyse multiple biomarkers. We aimed to validate a clinical workflow for quantifying PD-L1 in non-small cell lung...
9.
Humphries M, Craig S, Kacprzyk R, Fisher N, Bingham V, McQuaid S, et al.
BMC Cancer
. 2020 Jun;
20(1):500.
PMID: 32487090
Background: Limited studies examine the immune landscape in Esophageal Adenocarcinoma (EAC). We aim to identify novel associations, which may inform immunotherapy treatment stratification. Methods: Three hundred twenty-nine EAC cases were...
10.
Humphries M, Bingham V, Sidi F, Craig S, McQuaid S, James J, et al.
Cancers (Basel)
. 2020 May;
12(5).
PMID: 32365629
Targeting of the programmed cell death protein (PD-1)/programmed death-ligand 1 (PD-L1) axis with checkpoint inhibitors has changed clinical practice in non-small cell lung cancer (NSCLC). However, clinical assessment remains complex...